Search results

Filter

Filetype

Your search for "*" yielded 552701 hits

Awards for Leif Groop

Professor Leif Groop, international known diabetes researcher and coordinator of Lund University Diabetes Centre, is now assigned an other established award: Matti Äyräpää-award of 20 000 eur. The prize is awarded by the Finnish medical society Duodecim. Leif Groop who is born in Finland, has during his long carrier contributed to the increased knowledge of the genes roles when it comes to Type 2

https://www.ludc.lu.se/article/awards-leif-groop - 2026-01-09

Diabetes link with dementia to be examined

It is well known that type 2 diabetes raises the risk of dementia. The reasons for this are less clear, but one explanation could be insulin resistance in the brain, according to Malin Wennström, a researcher at Lund University´s Molecular Memory Research Unit. She has received EUR 700,000 from the Swedish Research Council to investigate her theory."The goal is to find measureable biomarkers early

https://www.ludc.lu.se/article/diabetes-link-dementia-be-examined - 2026-01-09

New findings on gastric bypass and diabetes

The majority of gastic bypass patients mysterioulsy recover from their type 2 diabetes within days, before any weight loss has taken place. A study at Lund University Diabetes Centre in Sweden has now shown that the insulin-producing beta cells increase in number and performance after the surgery. “We have suspected this for a while, but there have not previously been any models to prove it”, says

https://www.ludc.lu.se/article/new-findings-gastric-bypass-and-diabetes - 2026-01-09

Grants Hjelt foundation

Five researchers from Lund University and the University of Geneva has bedn granted altogether 200 000 Euro from Bo & Kerstin Hjelt Foundation for type 2 diabetes. Dr Jens Lagerstedt, Lund University: "Zinc transporter ZnT8 and type 2 diabetes" (€50 000)Dr Jonathan Esguerra, Lund University: "Characterization of non-coding RNAs in the pancreatic islets of Langerhans and identification of circulati

https://www.ludc.lu.se/article/grants-hjelt-foundation - 2026-01-09

Epigenetic changes could explain type 2 diabetes

People with type 2 diabetes have epigenetic changes on their DNA that healthy individuals do not have. This has been shown in a major study by researchers at Lund University. The researchers also found epigenetic changes of a large number of genes that contribute to reduced insulin production. “This shows that the risk of developing type 2 diabetes is not only genetic, but also epigenetic”, said C

https://www.ludc.lu.se/article/epigenetic-changes-could-explain-type-2-diabetes - 2026-01-09

Nanoparticles cause cancer cells to commit suicide

Using magnetically controlled nanoparticles to force tumour cells to ‘commit suicide’ sounds like science fiction, but could be a future part of cancer treatment. “The clever thing about the technique is that we can target selected cells without harming surrounding tissue”, said Professor Erik Renström from Lund University. In brief, the technique involves getting the nanoparticles into a tumour c

https://www.ludc.lu.se/article/nanoparticles-cause-cancer-cells-commit-suicide - 2026-01-09

Cystic fibrosis and diabetes link explained

“The increased risk of diabetes has previously been explained by the fact that cystic fibrosis causes damage to the pancreas, where the blood-sugar regulating hormone insulin is produced. We are the first research group to show that the mutated gene that causes cystic fibrosis also plays an important role in the release of insulin. The risk of diabetes is not only explained by the destruction of t

https://www.ludc.lu.se/article/cystic-fibrosis-and-diabetes-link-explained - 2026-01-09

100 millions to strengthen the Swedish life science sector

The Swedish Innovation Agency, VINNOVA, has granted 100 MSEK to the Strategic Innovation Programme, SIO Chronic Diseases, with the overall aim to create better health and increased growth in Sweden. If Sweden is to remain competitive on the global life science stage, the opportunities for turning research results into innovations providing growth and benefit for patients need to be improved. SIO C

https://www.ludc.lu.se/article/100-millions-strengthen-swedish-life-science-sector - 2026-01-09

Study of identical twins reveal type 2 diabetes clues

By studying identical twins, researchers from Lund University in Sweden have identified mechanisms that could be behind the development of type 2 diabetes. This may explain cases where one identical twin develops type 2 diabetes. The study involved 14 pairs of identical twins in Sweden and Denmark. One twin had type 2 diabetes and the other was healthy.“Twins are a good model for finding mechanism

https://www.ludc.lu.se/article/study-identical-twins-reveal-type-2-diabetes-clues - 2026-01-09

Lagerstedt and Stenkula receive Novo Seed Grant

Antidiabetics that also provide cardiovascular benefit is a key unmet need in diabetes treatment. ApoA-l is a protein shown to have both glucose lowering and cholesterol-lowering effects and has been investigated by Jens Lagerstedt and Karin Stenkula for its therapeutic potential. They have now received 2,5 million Danish kroner from the Novo Seeds for taking innvoation a step further. The goal is

https://www.ludc.lu.se/article/lagerstedt-and-stenkula-receive-novo-seed-grant - 2026-01-09

New method measures the risk of type 2 diabetes in blood

Researchers at Lund University in Sweden have found a new type of biomarker that can predict the risk of type 2 diabetes, by detecting epigenetic changes in specific genes through a simple blood test. “This could motivate a person at risk to change their lifestyle”, says Karl Bacos, researcher in epigenetics at Lund University. The results are published today in Nature Communications. Predicting t

https://www.ludc.lu.se/article/new-method-measures-risk-type-2-diabetes-blood - 2026-01-09

EASD: Protein predicts and mediates type 2 diabetes

Yang De Marinis is presenting new results on a protein that predicts and mediates typ 2 diabetes. Learn more about her and her research here. Yang De Marinis is currently an assistant professor at the Department of Clinical Sciences, Lund University. Dr. Yang De Marinis received her PhD degree in 2010 at Lund University on electrophysiology. She was then a Postdoc fellow between 2010-2015 in the l

https://www.ludc.lu.se/article/easd-protein-predicts-and-mediates-type-2-diabetes - 2026-01-09

EASD: Melatonin and risk for type 2-diabetes

One third of the population is more sensitive to melatonin and face a higher risk of getting typ 2-diabetes. Why this is so is a question for Claire Lyons to answer. Learn more about her and her research. Our body clock, or circadian rhythm, controls our daily activities over a 24h period but sometimes this rhythm can become disturbed by shift work, jet lag or even our genetics. The hormone melato

https://www.ludc.lu.se/article/easd-melatonin-and-risk-type-2-diabetes - 2026-01-09

The world's most cited researchers

Paul Franks, Leif Groop, Olle Melander and Peter Nilsson, are among the most cited researchers in the world, according to Web of Science. The list recognizes world-class researchers selected for their exceptional research performance, demonstrated by production of multiple highly cited papers that rank in the top one percent by citations for field and year in Web of Science.See full listAbout the

https://www.ludc.lu.se/article/worlds-most-cited-researchers - 2026-01-09

EASD: DPP-4 inhibition effects on glycemia and islet hormones in individuals with type 2 diabetes

Wathik Alsalim presented new findings on persistent whole day meal effects of three DPP-4 inhibitors on incretin- and islet hormones in metformin-treated type 2 diabetes Learn more about the study: Wathik Alsalim work as consultant in the Diabetes and Endocrinology Department at Skåne University Hospital, SUS, in Lund.- Since I was at university, I was interested in diabetes because it has been a

https://www.ludc.lu.se/article/easd-dpp-4-inhibition-effects-glycemia-and-islet-hormones-individuals-type-2-diabetes - 2026-01-09

Prestigious prize goes to pioneer of bioinformatics

Professor Søren Brunak from Copenhagen - member of the LUDC-IRC Scientific Advisory Board - has been awarded the grand Nordic Prize for 2019 by the Eric K. Fernström Foundation. It is one of the largest Scandinavian research prizes in medicine and Søren Brunak receives the award for his work as a pioneer in the borderland between mathematical analysis and biomedical research – a field that paves t

https://www.ludc.lu.se/article/prestigious-prize-goes-pioneer-bioinformatics - 2026-01-09

Medeon stipend 2019

The Medeon stipend for SEK 50.000 is given by Medeon Science Park in connection to Moll Wendén Advokatbyrå and this time it is associate professor Emma Ahlqvist who is awarded. "Docent Emma Ahlqvist is awarded 2019 years Medeon-stimpen for her pioneering research within genetics and diabetes. Her clinical subgrouping  of diabetes has won world reputation and will paves the way for better individua

https://www.ludc.lu.se/article/medeon-stipend-2019 - 2026-01-09

Hair-raising research could lead to diabetes treatment

Is it possible to conduct research on type 1 diabetes, type 2 diabetes and hair loss at the same time? Absolutely, says Pontus Dunér who after many years of secrecy can now lift the lid on and talk about his promising results. The common denominator is a protein that Pontus Dunér and his colleagues have worked on intensively in recent years to modify and break down into smaller active components,

https://www.ludc.lu.se/article/hair-raising-research-could-lead-diabetes-treatment - 2026-01-09